Skip to content
PeptideRank
MaxLife logo

Provider review

MaxLife cost: $195/mo tirzepatide

MaxLife itself has a real FDA warning letter (February 2026).

MaxLife (maxlife.com) received its own FDA warning letter — MaxLife Technologies Inc. dba Maxlife, MARCS-CMS 721453, February 20, 2026 — for a mislabeled-compounder template and misleading FDA-approval claims, the same mass-enforcement wave already documented for several peers here. Separately, its semaglutide page reveals that the homepage's "Starting at $155/mo" headline is a first-month rate. The standing price is $195/mo — 26% higher, and it applies to every month after the first.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What MaxLife discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Disclosed

Publishes which states it actually serves.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit MaxLife

Pharmacy

Not categorized

Labs

Not stated.

States

All 50 states

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not disclosed

The catch — The homepage's "Starting at $155/mo" semaglutide headline is reached only via a first-month promotional rate or a 3-month prepay ("$465 for 3 months") — never as an ongoing no-commitment monthly rate, which is $195/mo. Tirzepatide has no equivalent gap.

See plans at MaxLife

Prices read from MaxLife's own site · August 2026

What they advertise

MaxLife's own homepage states "Starting at $155/mo" (semaglutide) and "Starting at $195/mo" (tirzepatide). Its dedicated semaglutide page discloses "$155/First month Then $195/mo" for the Monthly Plan, plus a Quarterly Plan billing "$465 for 3 months." Its dedicated tirzepatide page states a flat "$195/mo" with no promo found.

What you actually pay

$195/month is the confirmed standing ("Then") price for semaglutide after the first month, and the flat, no-promo price for tirzepatide from the first order — off each product's own dedicated page.

The bottom line

MaxLife (maxlife.com, legal entity Maxlife Technologies Inc., Irvine, CA) sells compounded tirzepatide (flat $195/mo, no promo found) and compounded semaglutide (a $155/mo first-month rate that reverts to $195/mo), naming three fulfillment pharmacies directly on its homepage. Two real, independent findings: MaxLife's own FDA warning letter from the February 2026 mass-enforcement wave, and a confirmed promo-to-standing gap on its semaglutide pricing specifically (tirzepatide has no equivalent gap).

MaxLife appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You've read MaxLife's own FDA warning letter and are comfortable with the same mislabeled-compounder finding already disclosed for several peers here.
  • You want tirzepatide's true, flat, no-promo standing price up front — $195/mo, confirmed directly.
  • You want three fulfillment pharmacies named directly, even though none is tied to a 503A/503B category.

Look elsewhere if

  • You're budgeting around the homepage's "Starting at $155/mo" semaglutide headline — the true standing price is $195/mo, confirmed on MaxLife's own dedicated page.
  • You want every named pharmacy partner free of any FDA regulatory history — Strive Pharmacy has a real warning letter (2022/2023) already documented for two other providers here.
  • To cancel without notice matters — MaxLife's own FAQ requires "a cancellation notice at least 30 days before your next billing period begins."

What MaxLife offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

No category stated

MaxLife does not name the pharmacy that fills your prescription.

What its own site says

Unknown. Its own homepage names three fulfillment pharmacies directly, "Hallandale Pharmacy, Red Rock Pharmacy, and Strive Pharmacy," but ties none of them to a 503A/503B category anywhere checked.

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

All 50 states

All states. Its own homepage states plainly, "Maxlife.com provides services in all states across the United States."

The honest cons

The part they would rather you skipped

MaxLife itself — not just a named partner — has a real, current FDA warning letter, confirmed directly at its own fda.gov page: MaxLife Technologies Inc. dba Maxlife, MARCS-CMS 721453, February 20, 2026, citing a mislabeled-compounder template ("identifies '[name]' on the pictured label, suggesting [name] is the compounder when in fact it is not") plus misleading FDA-approval claims — the identical February 20, 2026 mass-enforcement wave already documented for Strut Health, MEDVi, 24HrDoc, Ivim, Viv, BluefitMD, Kin Meds, Join Josie, and Momentum Health 360, not a distinct or unusual action. Per the standing rule already applied to those peers, this alone does not disqualify MaxLife; a targeted search for independent journalism documenting fabricated physician personas or deepfaked patient photos (the MEDVi-class disqualifier) came back empty. Separately, one of its three named pharmacies, Strive Pharmacy, carries its own separate FDA warning letter (2022/2023) — the same finding already made for Bionomy Health and Care Bare Rx. Also separately, its own homepage "Starting at $155/mo" semaglutide headline is a first-month/3-month-prepay rate; the true standing price is $195/mo, 26% higher.

  • MaxLife itself has a real FDA warning letter (February 2026) for a mislabeled-compounder template and misleading FDA-approval claims.
  • Its own "Starting at $155/mo" semaglutide headline is a promo/prepay rate — the true standing price is $195/mo.
  • One of its three named pharmacies, Strive Pharmacy, has its own separate FDA warning letter.

None of this is unique to MaxLife — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.

Ready to get started?

Prices and plans in this category change often — check MaxLife's current pricing before you decide. Ours was read from their own site in August 2026.

See MaxLife pricing

Facts on this page reflect MaxLife's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on MaxLife's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.

MaxLife

2 compounds from $195/mo

Visit